Immunoprecise Antibodies Ltd IPA

Technology Scientific & Technical Instruments

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd > Contract Research Org. versus Internal Research

<< Previous

Bullboard Posts

Next >>

Comment by dart321on Jul 28, 2021 12:48pm

201 Views

Post# 33617128

RE:Contract Research Org. versus Internal Research

To me it looked like this last pump was to get certain institutions that where stuck in this stock, out. Now it will likely drift back to where it should be which is 2 times sales plus cash on hand or about $5.70 to $6.10 per share Canadian.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth